Pharma Mar S.A.
Biopharmaceutical company developing oncology treatments from marine sources.
PHM | MC
Overview
Corporate Details
- ISIN(s):
- ES0169501022 (+1 more)
- LEI:
- 959800QWKZ45ZQC2AV58
- Country:
- Spain
- Address:
- Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo
- Website:
- https://pharmamar.com/en/
- Sector:
- Manufacturing
Description
Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-10 17:42 |
La Sociedad anuncia la convocatoria de la Junta General Ordinaria de Accionista…
|
Spanish | 265.9 KB | ||
| 2021-03-01 09:22 |
La Sociedad anuncia la firma de un nuevo acuerdo de licencia con Adium para com…
|
Spanish | 470.0 KB | ||
| 2021-02-26 18:00 |
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
|
Spanish | 240.1 KB | ||
| 2021-02-26 00:00 |
Corporate Governance Report - Pharma Mar S.A.
|
Spanish | 240.1 KB | ||
| 2021-02-26 00:00 | Spanish | 2.1 MB | |||
| 2021-02-26 00:00 | Spanish | 5.4 MB | |||
| 2021-02-26 00:00 | Spanish | 4.6 MB | |||
| 2021-02-17 10:55 |
La Sociedad anuncia la obtención de la autorización de la Agencia Británica del…
|
Spanish | 100.6 KB | ||
| 2021-02-01 08:25 |
La Sociedad remite nota de prensa relativa a la presentación de nuevos datos de…
|
Spanish | 140.7 KB | ||
| 2021-01-26 07:41 |
La Sociedad informa de la publicación del artículo de investigación “Plitidepsi…
|
Spanish | 115.3 KB | ||
| 2021-01-07 18:14 |
La Sociedad remite detalle de las operaciones del Contrato de Liquidez comprend…
|
Spanish | 113.8 KB | ||
| 2020-12-11 13:55 |
La Sociedad informa de la sustitución del representante persona física del cons…
|
Spanish | 168.1 KB | ||
| 2020-12-09 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2020-12-03 08:22 |
La sociedad anuncia resultados del estudio de fase III ATLANTIS con lurbinected…
|
Spanish | 130.5 KB | ||
| 2020-11-24 08:48 |
La Sociedad informa que su filial Genomica, S.A.U., ha obtenido el marcado CE d…
|
Spanish | 78.0 KB |
Automate Your Workflow. Get a real-time feed of all Pharma Mar S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharma Mar S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharma Mar S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
